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ABSTRACT 
Globin mRNA levels in  11-15-day mouse fetal liver cells have been estimated by in 
situ hybridization of a highly labeled DNA copy (cDNA) of adult globin messenger 
RNAs  (mRNAs)  (globin  cDNA)  to  fixed  preparations  of  cells.  Under  the 
conditions  employed,  no  significant  in situ  hybridization  occurred to  lymphoma 
cells (L 51787),  mouse  L  cells, or hepatocytes; whereas reticulocytes from phenyl 
hydrazine-treated  mice showed extensive in situ hybridization.  The proportion of 
fetal liver cells showing predominantly cytoplasmic in situ hybridization increased 
from about 30% at the  1 lth day of development to 80-85% by days 13-15. Unlike 
more mature cells, proerythroblasts did not show in situ hybridization, except to a 
slight extent at later stages of development. These studies therefore indicate that 
globin  mRNAs  begin to  accumulate during  or shortly after the proerythroblast- 
basophilic erythroblast transition. 
The  fact that  certain  immature erythroid  cells  from  14-day  fetal liver contain 
substantial  amounts  of  globin  mRNAs  has  been  confirmed  by  comparing  the 
hybridization  in  solution  of globin  cDNA  to  cytoplasmic RNA  extracted  from 
total  fetal liver cells or  from immature erythroid  cells  obtained  by treatment  of 
fetal liver cells with an antiserum  raised against erythrocytes. 
During  the  llth-16th  day  of  fetal  mouse 
development,  the  liver  becomes  the  main 
erythropoietic organ.  At this time, the fetal liver 
consists of up to 70% erythroid cells,  comprising 
both multipotential and intermediate "'stem cells" 
and  all  the  recognizable  erythroid  cell  types. 
Although erythroid cell development represents a 
continuous  process,  certain  erythroid  cell  types 
have been classified,  as summarized in the scheme 
below [see (1, 2) for review]: 
proerythroblast ---, basophilic erythroblast -~ 
polychromatic erythroblast --* orthochromatic 
erythroblast --, reticulocyte ---, erythrocyte 
The most immature recognizable erythroid cells 
(proerythroblasts and basophilic erythroblasts) do 
not contain detectable amounts of hemoglobin as 
determined by histochemical staining or synthesis 
of globin chains (3); hemoglobin is first detected in 
a more mature cell type, the polychromatic eryth- 
roblast stage. An important question is, therefore, 
whether globin  messenger RNA (mRNA) can be 
detected  at  an  earlier  developmental  stage  than 
hemoglobin,  in  the  proerythroblast or basophilic 
erythroblast.  An  answer  to  this  question  would 
enable certain conclusions to be drawn concerning 
the  mechanism of control  of hemoglobin forma- 
tion during erythroid cell maturation. 
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whereby  cellular  globin  mRNA  can  be  detected 
autoradiographically  in  fixed preparations  of spe- 
cific cell types  by  in situ  hybridization  to  a  very 
highly  labeled  DNA  copy  (cDNA)  of  purified 
globin  mRNA  obtained  by  transcribing  mouse 
reticulocyte 9S RNA with viral reverse transcript- 
ase.  This work  also demonstrated  the presence of 
globin  mRNA  in  basophiiic  erythroblasts  from 
13-day  fetal  livers;  whereas  little  globin  mRNA 
could be detected in the more immature proeryth- 
roblasts.  However,  Terada  et  al.  (3)  have  not 
detected significant amounts of translatable globin 
mRNA  in  immature  erythroid  cells (a  mixture of 
proerythroblasts  and  basophilic erythroblasts  ob- 
tained by treatment of total fetal liver cells with an 
antiserum  raised  against  mature  red  blood  cells), 
as judged by the ability to direct globin synthesis in 
the  Krebs  ascites  lysate  system.  These  reports 
therefore  suggest  the  interesting  possibility  that 
during erythroid cell differentiation globin mRNA 
may be synthesized before the immature erythroid 
cell  has  the  capacity  to  translate  it  into  globin 
chains. 
A  related  question concerns the stabilization  of 
the  hemoglobin  synthetic  capacity  at  about  the 
12th  13th  day  of fetal  liver development.  Before 
this  time,  hemoglobin  synthesis  in  fetal  livers  is 
dependent  on  continued  RNA  synthesis;  subse- 
quently,  inhibition  of  RNA  synthesis  does  not 
affect the synthesis of hemoglobin. This change is 
not due to accumulation of larger numbers of more 
mature erythroblasts during development (5).  It is, 
therefore,  of  considerable  interest  to  ascertain 
whether  this  change  is  reflected  in  the  types  of 
erythroid  precursor  cells in  which  globin  mRNA 
can be detected. 
The present paper therefore attempts to analyze 
these  two  questions  in  more  detail.  First,  globin 
mRNA  levels in specific erythroid cell types from 
fetal livers of different ages  are determined  by in 
situ hybridization  to  globin  cDNA.  These  results 
are  then  confirmed  by  estimating  globin  mRNA 
levels  in  total  or  immature  erythroid  cells  (ob- 
tained  by  treatment  of total  fetal  liver cells with 
antiserum,  as  described  above)  by  titrating  ex- 
tracted  cytoplasmic  RNA  with  globin  cDNA. 
Although  the  latter  approach  does  not yield such 
detailed  information  with  respect  to  the  distribu- 
tion  of  globin  mRNA  in  specific  erythroid  cell 
types at different stages of fetal liver development, 
it  does  facilitate  an  analysis  as  to  whether  the 
globin  mRNAs  synthesized  in  total  or  immature 
fetal  liver  cells  are  the  same  as  those  in  adult 
reticulocytes,  namely a- and/3-globins. 
MATERIALS  AND METHODS 
Preparation  of Globin  cDNA 
[3H]DNA  complementary  to  globin  mRNA  (globin 
cDNA) was  synthesized  by copying mouse reticulocyte 
9S RNA with reverse transcriptase prepared from avian 
myeloblastosis  virus  as  described  previously  (6-9). 
cDNA  prepared  in  this  way  represents  a  faithful  but 
partial, transcript of a  and/3 globin mRNAs (8, 9). 
In Situ Hybridization 
Procedures  for obtaining  fetal livers,  preparation  of 
slides,  and  in  situ hybridization  of eDNA  have  been 
described in detail (4). After treatment for 25 min in 0.2 
N  HCI  at  20°C  and  dehydration  in  ethanol,  slides 
bearing about  105 fixed cells were incubated at 43°C for 
18 h with  about 4/11 cDNA (25-50  x  10  e dpm/ug; 4  x 
107 dpm/ml) dissolved  in 0.45  M NaC1, 0.045  M citrate 
(3x  SSC)  containing  40%  formamide;  washed  in  2x 
SSC at 20°C; incubated  for  1  2 h  at 55°C in 2x  SSC; 
and finally washed  in 2x SSC. Autoradiographs (ARI0) 
were  prepared  and exposed  for 6-7 wk.  Cells were then 
stained with May-Griinwald and Giemsa stains. 
Purification  of Immature  Erythroid  Cells 
by  Treatment  with Antiserum 
Rabbit antiserum against adult mouse red blood cells 
[obtained  as described  by Cantor  and  co-workers (10)] 
had a titer of 1:2,000 for lysis of mouse red blood cells in 
the presence of guinea pig complement. 14-day fetal liver 
cells were treated with antiserum exactly as described by 
Terada  et  al.  (3), except that  antiserum  was  used  at  a 
dilution of 1:200. About 1-2% of the total fetal liver cells 
were  recovered by this  procedure  and  these comprised 
86%  immature erythroid ceils (i.e.  proerythroblasts and 
basophilic  erythroblasts)  and  7%  hemoglobinized cells. 
Accurate cell counts were obtained by adding  a known 
number  of  red  blood  cells  to  immature  cell  samples 
before preparing slides and then by obtaining a differen- 
tial cell count. 
Extraction  of Cytoplasmic RNA 
Erythroid cells were  suspended  (2  x  10  * cells/ml) by 
gentle  homogenization  in  0.14  M  NaCI,  0.01 M  Tris- 
HCI,  1.5  mM  magnesium  acetate  and  0.5%  Nonidet 
NP-40,  allowed  to  stand  at  0°C  for  2  min,  and  then 
centrifuged for 10 min at  1,000 g. Microscope examina- 
tion of the pellet fraction showed  that most of the cells 
had been lysed by this procedure and that most erythroid 
cell  nuclei  remained  intact.  Sodium  dodecyl  sulphate 
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mixture extracted  repeatedly  with  an  equal  volume of 
phenol/chloroform  (1:1 vol/vol)containing  1%  amyl 
alcohol until no protein at the interface was visible. RNA 
was obtained by precipitation with 2 vol of ethanol after 
adjusting the salt concentration to 0.2 M, and purified by 
dissolving in 0.2  M NaCI and reprecipitating again with 
ethanol. 
Hybridization of RNA  to eDNA 
eDNA  (sp  act  45  x  l0  s dpm/~tg)  was  dissolved  in 
hybridization  buffer (0,5  M  NaCI, 25 mM HEPES, 0.5 
mM  EDTA,  containing  50%  formamide,  pH  6.8)  at 
about 0.2 ~g/ml. Serial dilutions of RNA from erythroid 
cells (0  15 mg/ml) were prepared in hybridization buffer 
also  containing 4  mg/ml E. coli RNA as carrier.  5-#1 
portions each  of eDNA and  each dilution of erythroid 
RNA were mixed, sealed in a capillary, and incubated at 
43°C for 7 days.  We have shown  previously (8, 9) that 
under  these  conditions,  hybridization  to  cDNA of any 
complementary  RNA  sequences  present  in  the  RNA 
samples will be complete. Each sample was then assayed 
for  hybrid  formation  by  treatment  with  single-strand 
specific nuclease or by banding in CsCI after ribonuclease 
treatment exactly as described previously (8, 9). 
Determination of Melting  Temperatures 
Hybrids were formed as described above at an RNA/ 
cDNA  ratio  slightly in  excess of that  required to  give 
the  maximum  hybridization  of eDNA.  Hybrids  were 
diluted in 0.5 M NaCI, 25 mM HEPES, 0.5 mM EDTA, 
pH 6.8, resealed  in capillaries, and then heated for 5 min 
at  various  temperatures  in  the  range  43  90°C.  Capil- 
laries  were  then  immersed  in  an  ice/salt  mixture,  ex- 
pelled with S1 nuclease  buffer and assayed for resistance 
to SI nuclease exactly as described previously (8). 
Determination of Cellular RNA  Content. 
Known numbers of cells were treated at 0°C with 0.2 
N  HCIO,  and  the  precipitate  was  washed  extensively 
with 0.2 N HC10~. After digesting the precipitate in  1 N 
NaOH for 4 h at 37°C, 1/4 vol of 6 N HCIO4 was added 
and  the precipitate centrifuged down after allowing the 
acidified  mixture  to  stand  for  30  rain  in  ice.  RNA 
determinations  were  calculated  from  the  E~o  of  the 
supernatant  fraction. 
RESULTS 
In Situ Hybridization 
NONERYTHROID  CELLS:  The  conditions  of 
in  situ  hybridization  and  subsequent  washing  of 
cells  at  elevated  temperature  were  designed  to 
eliminate nonspecific adsorption  of cDNA to fixed 
preparations  of cells (4).  Under  these  conditions, 
only  slight  in  situ  hybridization  of  cDNA  to 
mouse  LS  cells,  lymphoma  cells  (L  5178Y)  or 
hepatocytes  as observed  (Figs.  !-3). 
RETICULOCYTES:  Since  cDNA  is  obtained 
by  transcribing  9S  RNA  from  mouse  reticulo- 
cytes,  one  would  expect  cDNA  to  show  good  in 
situ hybridization to reticulocytes.  In the past, this 
has been difficult to achieve, and various explana- 
tions  have  been  suggested  (4).  However,  recently 
we have  repeatedly  obtained  extensive in situ hy- 
bridization of cDNA to fixed preparations of retic- 
ulocytes (Fig. 4).  In these successful experiments, 
the  cell  concentration  on  the  slides  was  reduced 
considerably  compared  to  the  previous  unsucces- 
ful experiments,  so that  the  reticulocytes were far 
from confluent (Fig. 4).  Assuming that  the globin 
mRNA content of a single reticulocyte is 3  x  10-2 
pg  [i.e.  1.5%  of the  total RNA  (1 l)], calculations 
show that the ratio of cDNA to reticulocyte globin 
mRNA during in situ hybridization was about  1:3 
in  the  previous experiments  and  about  3:1  in  the 
present  experiments.  This  may  mean  that  it  is 
important  to  maintain  an  adequate  eDNA to cell 
ratio during in situ hybridization. 
13-15-DAY  FETAL  LIVER  CELLS:  As  is 
evident from  Fig.  5  and Table  I,  most  cells from 
! 3-15-day fetal livers undergo extensive in situ hy- 
bridization  with globin cDNA.  However, the very 
largest  cells  (diameter  greater  than  15  gin),  with 
characteristics  of  proerythroblasts,  form  in  situ 
hybrids much less frequently than the smaller cells 
including  those  which  exhibit  characteristics  of 
basophilic  erythroblasts  (Fig.  5).  In  fact,  only 
about  15%  of  the  proerythroblast  compartment 
shows  diffuse  labeling  over the  whole cell (Table 
I). Owing to the high grain counts on these slides, 
it is difficult to be more precise in the identification 
of more mature erythroid cell types, except on the 
basis  of size,  Nevertheless,  it  is  clear  that  during 
thel3th-15th  day  of  development  erythroid  cell 
types  of size  8-12  ~tm  show extensive in situ hy- 
bridization to giobin cDNA. 
I I  12-DAY  FETAL  LIVERS:  During  growth 
from the  1 lth  12th day of fetal liver development, 
the  proportion  of  proerythroblasts  decreases 
markedly from about  80% to about 20%, and ma- 
ture erythroid cells (polychromatic and orthochro- 
matic  erythroblasts),  which  are  totally  absent  at 
the  I lth day, begin to accumulate. The results col- 
lected in Table  I  show that  the proportion  of cells 
showing in silu hybridization  to globin eDNA in- 
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FIGURE 1  Amouse L cell line (LS). 
FIGURE 2  Lymphoma cells (L 5178Y). 
FIGURE 3  A group of hepatocytes  (Hep), adjacent to erythroid cells which are labeled. Autoradiographic 
exposure:  6 wk. The magnification in Figs.  1-9 is x  1,400, and the bar represents  10 ~,m, 
FIGURE 4  In situ hybridization of globin cDNA to reticulocytes.  Autoradiographic exposure:  6 wk. 
creases  progressively as the livers develop during 
the 1 lth-13th days. As is evident from Figs. 6 a-c, 
this  occurs because proerythroblasts from  11-12- 
day  fetal  livers do  not form  in  situ  hybrids with 
globin cDNA  to  any great  extent,  as  is also  the 
case  for  proerythroblasts  from  13-i5-day  fetal 
livers (Fig. 5 a).  Moreover,  any in situ hybridiza- 
tion to  proerythroblasts  is relatively diffuse  over 
tile whole cell rather than locmalized over the cyto- 
plasm (Fig. 6 c). However, proerythroblasts show- 
ing such diffuse labeling represent only about 2% 
of the proerythroblast compartment; this figure is 
much  lower  than  that  for  13-15-day  fetal  livers 
(Table  I).  The  remarkable  impression  obtained 
from thorough scanning of these in situ hybridiza- 
tion  slides  is  that  there  appears  to  be  a  sudden, 
rather  than  a  gradual, increase in globin mRNA 
content in cells of decreasing size: larger cells ap- 
pear to  be labeled slightly in a  diffuse manner, if 
at all; smaller cells are very heavily labeled exclu- 
HARRISON ET  AL.  In Situ Localization  of Globin  Messenger  RNA Formation. 1  405 FIGURE 5a  b  In situ hybridization of globin cDNA  to  13-day  fetal liver cells.  Pr, proerythroblast; B, 
basophilic erythroblast. Autoradiographic exposure: 6 wk. 
FIGURE 6a-c  In  situ  hybridization of globin  cDNA  to  ll-12-day  fetal  liver cells.  Autoradiographic 
exposure: (a) and (b), 6 wk; (c)  10 wk. 
FIGURE  7  Basophilic erythroblast (B), polychromatic nucleated erythrocyte (PNE), and orthochromatic 
nucleated erythrocyte (ONE) from  I 1-day  fetal liver. 
406 TABLE I 
Percentage of Fetal Liver Cells Showing In Situ 
Hybridization to Globin cDNA 
Proerythroblast 
compartment  showing 
Age  Positive  cells  diffuse labeling 
days  %  % 
11  33  ~2 
12  55 
13  78  ~15 
14  85 
15  84 
Each value is the average of two measurements on slides 
exposed  for 6-7 wk or  10 wk. Cells showing predomi- 
nantly cytoplasmic labeling with more than  15  grains 
were scored as positive. 
sively  in  the  rim  of  cytoplasm.  Some  of  the 
smaller, labeled  cells  appear  to  be  typical baso- 
philic erythroblasts,  but  the  majority are  some- 
what  smaller  basophilic  cells.  The  smaller  cells 
which  form in situ hybrids are too numerous to be 
accounted for by the very small proportion of ma- 
ture  hepatic erythroid  cells  in livers of this age. 
They are also too numerous to be polychromatic 
or orthrochromatic nucleated erythrocytes derived 
from  the yolk-sac; moreover, their appearance is 
characteristically different from that of the nucle- 
ated erythrocytes (Fig. 7). 
IMMATURE  CELLS FROM  14-DAY  FETAL 
LIVERS:  Since the  proportion of immature cells 
in fetal liver declines rapidly after the  l lth  12th 
day, it is not possible to determine directly whether 
all proerythroblasts remain free of hybrid after in 
situ  hybridization and whether  the characterstic- 
ally small immature erythroblasts forming exten- 
sive in situ hybrids with cDNA persist during fetal 
liver development. However,  it is  possible to ap- 
proach  this  question indirectly by removing ma- 
ture  erythroblasts  from  preparations  of  14-day 
livers by the use of a specific antiserum. After such 
treatment,  the  proportions  of  the  various  ery- 
throid  cell  types  are  altered  as  shown  in  Fig.  8 
a-b and quantified in Tabe II. Immature cells ob- 
tained by this procedure were then allowed to hy- 
bridize with globin cDNA in situ in the usual way. 
It  is clear from the  results (Fig. 9  a  b) that the 
cells  which  form  extensive  in  situ  hybrids  with 
globin  cDNA  have  characteristics  very  similar 
to  those  of  the  immature cells  from  ll-12-day 
fetal liver. Any large proerythroblasts which show 
in situ hydridization are much less heavily labeled 
and tend to show hybridization generally distrib- 
uted over both nucleus and cytoplasm. 
Conventional  Hybridization  Studies 
It  is  obviously  desirable  to  confirm  by  an 
independent method the conclusions derived from 
studies using in situ hybridization. Immature cells 
from  14-day  fetal  livers  were  first  obtained  by 
treatment  with  antiserum  raised  against  mature 
red  blood cells  as  described  above.  Cytoplasmic 
RNA  was  then  extracted  from  either  total  or 
immature erythroid  cells  and the  globin mRNA 
content  in  these  RNA  preparations  was  deter- 
mined by titration with globin cDNA. The theo- 
retical  and  experimental  basis  of  this  titration 
method has been validated rigorously in previous 
papers (8, 9). A constant amount of highly labeled 
globin cDNA was annealed under stringent condi- 
tions with increasing amounts of RNA of interest, 
under  conditions in  which  hybridization of  any 
complementary sequences present is known to be 
complete  (9).  In  this  way,  a  titration  curve  is 
obtained showing how  the  proportion  of cDNA 
hybridized varies with RNA/cDNA ratio. 
It is clear from Fig.  10 that negligible amounts 
of cDNA are converted into hybrid by annealing 
with  8,000  times excess  cytoplasmic RNA  from 
lymphoma  cells.  Thus  cytoplasmic  RNA  se- 
quences present in a  nonerythroid mouse cell line 
(but of hematopoietic origin) do  not hybridize at 
all with globin cDNA under the conditions used as 
assayed by resistance to single strand-specific (S 1) 
nuclease. However, about 85% ofcDNA sequences 
are  hybridized  after  annealing under  the  same 
conditions  with  about  2  times  excess  globin 
mRNA from adult mouse reticulocytes or about 
1,000 times excess cytoplasmic RNA from 14-day 
fetal  liver erythroid  cells,  or  about  8,000  times 
excess cytoplasmic RNA from immature erythroid 
cells (Fig.  10). 
It is obviously of interest to determine precisely 
the  extent of sequence complementarity between 
globin cDNA and the RNA sequences from fetal 
liver cells to  which  it  hybridizes. Therefore,  hy- 
brids  formed  between  globin  cDNA  and  RNA 
from  total  or  immature  erythroid  cells  were 
treated  with  ribonuclease  and  banded  in  CsCI. 
After annealing of globin cDNA with either total 
or  immature  erythroid  cell  cytoplasmic  RNA 
under conditions which converted 60-70% of glo- 
bin  cDNA  to  SI  nuclease-resistant  hybrid,  a 
similar proportion of the cDNA was converted to 
HARRISON ET  AL.  In Situ Localization of Globin Messenger RNA  Formation. 1  407 FIGURE 8  |4-day  fetal liver cells (a)  before or  (b)  after  treatment  with antiserum  raised against 
erythrocytes. 
FIGURE 9a-b  In situ hybridization of globin cDNA to immature erythroid cells from 14-day fetal liver 
ceils treated with antiserum. Autoradiographic exposure: 6 wk. 
ribonuclease-resistant hybrid banding in CsC1 at a 
density  of  1.78 (Fig.  11). Melting temperatures 
(Tm) of usch  hybrids were  also determined in 0.5 
M  NaC1, 50% formamide in the presence of excess 
E. coli RNA (Fig. 12). Under these conditions the 
Tm of globin cDNA/mouse reticulocyte 9S RNA 
was  68°C;  the  same  Tm  was  obtained  if  the 
hybridization and melting were  performed in the 
presence of 40,000 times excess  lymphoma cyto- 
plasmic RNA.  However,  the  Tm  of hybrids be- 
tween globin cDNA and immature erythroid cell 
cytoplasmic RNA was found to be 5  6°C below 
that  of  hybrid  between  globin cDNA  and  total 
erythroid  cell  cytoplasmic  RNA,  which  was,  in 
turn,  4°C  below  that  of hybrid  between  globin 
cDNA and mouse reticulocyte 9S RNA. Evidence 
that these reductions in Tm are not entirely due to 
nucleases contaminating the fetal liver cell RNA 
preparations  or  to  other  trivial reasons was  ob- 
tained  by  measuring  the  Tm  of  hybrid  formed 
between cDNA and 5 times excess 9S RNA in the 
presence  of excess  fetal liver RNA. These RNA 
ratios  were  arranged  so  that  the  amount  of 
"endogenous"  globin  mRNA  in  the  fetal  liver 
RNA was only one-fifth of the amount of9S RNA 
added.  Thus  the  sequences  which  hybridize  to 
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Effect of Treatment with Antiserum on the Erythroid Cell Types in 14-Day Fetal Liver 
Erythroblasts 
Proerythro-  Poly-  Ortho-  Reticulo-  Nucleated  Hepato-  Other 
blasts  Basophilic  chromatic  chromatic  cytes  erythrocytes  cytes  types 
Untreated  13  32  23  13  7  3  6  2 
After treatment  51  35  3  2  1  1  4  3 
with immune 
antiserum 
Results from the three experiments described  in  the text. The proportion  of orthochromatic erythroblasts  in the 
preparations  of total  fetal  liver cells  is  somewhat  lower than  that  reported  previously using  the  trypsinization 
procedure to obtain single cell suspensions  (18). 
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FIGURE 10  Titration of globin cDNA with mouse reticulocyte 9S RNA (A), lymphoma cell cytoplasmic 
RNA (11), 14-day fetal cell cytoplasmic RNA (O), or immature erythroid cell cytoplasmic RNA (O). The 
values for the proportion of globin cDNA hybridized have been normalized to correct for the percentage of 
the  eDNA  which  failed  to  form  S1  nuclease-resistant  hybrid  even  after  annealing  at  the  highest 
RNA/cDNA ratios (23%, O; 27%, O). 
cDNA  are  mainly  derived  from  the  added  9S 
RNA;  yet  the  hybridization  mixture  contains  a 
very large excess of fetal liver RNA.  The  results 
shown in Fig.  12 A  indicate that the Tm of the 9S 
RNA/cDNA  hybrid  was  not  reduced  by  the 
presence  of excess  cytoplasmic  RNA  from  total 
fetal  liver  cells;  whereas  the  Tm  of  9S  RNA/ 
cDNA hybrid was reduced by about 3-4°C by the 
presence of excess cytoplasmic RNA from imma- 
ture  fetal  liver  cells.  These  control  experiments 
thus show that the Tm's of hybrids between cDNA 
and cytoplasmic RNA from both total and imma- 
ture  fetal liver cells are  both  about  5-6°C  lower 
than  expected  by  comparison  with  that  of  9S 
RNA/cDNA  hybrid.  This means that  on average 
the  cytoplasmic  RNA  sequences  from  both  total 
and  immature  erythroid  cells  which  hybridize  to 
globin  cDNA  contain  about  4%  base  sequence 
differences relative to a- or 0-globin mRNA  (12, 
13).  It  is  therefore  possible  that  both  total  and 
immature  erythroid  cells  from  14-day  fetal  liver 
contain globin mRNAs other than those specifying 
a-  and  0-globins,  for  example  those  specifying 
z-globin chains, which have 14% amino acid differ- 
ences to O-chains (14). 
The  precise  concentration  of  these  globin 
mRNAs in a given cytoplasmic RNA preparation 
can  be estimated  by comparing  its titration curve 
with globin cDNA with the corresponding titration 
curve for globin mRNA. The titration curves only 
approximate  to  linear  forms  due  to  the  size 
heterogeneity of cDNA (9).  The  results  shown  in 
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FIGURE  11  Banding  of RNA/cDNA hybrids in CsCI. 
Globin cDNA was annealed with cytoplasmic RNA from 
(a) 14-day fetal liver cells or (b) from immature erythroid 
cells at  RNA/cDNA ratios of 1,000 or 40,000,  respec- 
tively.  The  annealed  mixture  (containing  about  5,000 
cpm.  of labeled cDNA) was  then  treated  with  ribonu- 
clease  and  then  banded  in  CsC1.  A  and  B  mark  the 
buoyant  densities of cDNA and  40%  G  +  C  synthetic 
hybrid respectively.  -, density of Cst~l. 
Fig.  10 show that the three titration curves for 9S 
RNA, total and immature erythroid cell cytoplas- 
mic RNA are nearly superimposable if the scale of 
the  abscissae  for the  three  RNA  fractions  are  in 
the  ratios  1:400:3,200.  This  means  that  globin 
mRNAs  comprise 0.25%  and 0.03%,  respectively, 
of  total  and  immature  14-day  fetal  liver  cell 
cytoplasmic  RNA.  The  results  of  three  such 
experiments  indicate  that  the  concentration  of 
globin mRNA in immature erythroid cell cytoplas- 
mic  RNA  is  15  40%  (actual  values:  24,  13,  and 
41% of the concentration of globin mRNA in total 
erythroid  cell cytoplasmic  RNA).  Since the aver- 
age  amounts  of  cytoplasmic  RNA  in  total  and 
immature  erythroid  cells  are  about  6  and  14 
pg/cell,  respectively,  this  means  that  the  average 
globin mRNA content of immature erythroid cells 
is about 60%  of total  14-day liver cells. 
It  might  be  argued  that  the  lower  content  of 
globin mRNA  in  immature  cells could  be due to 
degradation  of globin mRNA during treatment of 
cells  with  antiserum  and  complement.  Since  our 
antiserum  acts  against  mature  erythroid  cells 
mainly  by  agglutination,  it  is  possible  to  recover 
total erythroid  cells treated with complement and 
antiserum  simply  by  omitting the  usual  filtration 
steps. Cells obtained by such a modified procedure 
have  virtually  the  same  distribution  of erythroid 
cell types as the total, untreated, fetal liver cells. In 
two experiments, the proportion  of globin mRNA 
in  cytoplasmic  RNA  obtained  from  antiserum- 
and  complement-treated  total  fetal  liver cells,  as 
determined  by titration  with globin cDNA. Thus, 
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FIGURE 12  Tms of RNA/cDNA hybrids.  A. [] Mouse 
reticulocyte 9S  RNA/cDNA hybrid; •  hybrid  formed 
between  cDNA and a mixture of 5 times excess reticulo- 
cyte 9S RNA and 2,000 times excess cytoplasmic RNA 
from  total  fetal  liver ceils;  E)  hybrid  formed  between 
cDNA and  8,000  times excess  cytoplasmic RNA from 
total  fetal  liver  cells.  B.  []  Mouse  reticulocyte  9S 
RNA/cDNA hybrid; O  hybrid formed between  cDNA 
and a mixture of 5 times excess reticulocyte 9S RNA and 
40,000  times excess cytoplasmic RNA from lymphoma 
cells; •  hybrid formed between cDNA and a mixture of 5 
times  excess  reticulocyte  9S  RNA  and  10,000 times 
excess cytoplasmic RNA from immature fetal liver cells; 
(9 hybrid formed between cDNA and 10,000 times excess 
cytoplasmic RNA from immature fetal liver cells. 
g.lobin  mRNA  is not specifically degraded during 
treatment  of fetal  liver cells  with  antiserum  and 
complement. 
Alternatively, it might be argued that increased 
degradation  of globin  mRNA  occurs  during  ex- 
traction of cytoplasmic RNA from immature cells, 
for  example  due  to  increased  nuclease  levels  in 
immature erythroid cells. In order to examine this 
possibility  the  globin  mRNA  content  was  deter- 
mined for approximately equal numbers of total or 
immature  cells  and  for  a  mixture  of  the  same 
numbers  of total  and  immature  cells (Table  III). 
The globin mRNA content of the mixture of total 
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Globin mRNA  Content of Total and~or Immature 
Cell Cytoplasmic RNA 
Amount  RNA  RNA as 
Source of RNA  extracted  globin  mRNA 
ug  % 
Total cells  156  0.135 
Immature cells  322  0.055 
Mixed total and  426  0.079 
immature cells  (Predicted*: 
o.081) 
* Predicted  average for  mixture  from the  individual 
results for total and immature cells. 
and immature cells  is exactly the value expected 
from the individual values (Table III). This indi- 
cates  that  degradation  of globin mRNA during 
extraction of immature cells is not the explanation 
as to why the globin mRNA content of cytoplas- 
mic RNA from these cells is lower than that  for 
total fetal liver cells. 
DISCUSSION 
Validity of In Situ Hybridization of 
Globin eDNA  to Measure Cystoplasmic 
Globin mRNA 
The  present  results  show  that  globin  eDNA 
forms in situ hybrids with fixed slide preparations 
of reticulocytes under conditions in which no such 
hybridization to nonerythroid mouse cells (LS or 
iymphoma cells, hepatocytes) occurs. Since reticu- 
locytes hybridized under these conditions develop 
at least 200 grains in 7 wk, this implies, assuming 
an autoradiographic efficiency of 10%, that at least 
10 -s pg of globin cDNA is hybridized per reticulo- 
cyte,  i.e.  about 2%  of the  input level  of eDNA. 
Since giobin eDNA probably comprises transcripts 
of rather more than half the sequences present in 
both a- and B-globin mRNAs (8,  9),  this means 
that  the  in  situ  hybridization detects  about 2  × 
10 -3 pg of a- and B-globin mRNAs per reticulo- 
cyte,  i.e.  about  0.1%  of  the  total  cytoplasmic 
RNA. This is about one-twentieth of the propor- 
tion of globin mRNAs in reticulocyte polysomal 
RNA  as estimated in this laboratory by conven- 
tional RNA-cDNA hybridization (11). This failure 
to form in situ hybrids with the bulk of the mRNA 
in fixed preparations of reticulocytes illustrates the 
difficulties in obtaining quantitative estimates of 
globin mRNAs by this method. 
With  the  exception  of  proerythroblasts,  most 
erythroid cells (including basophilic erythroblasts) 
from  13-15-day fetal liver show extensive in situ 
hybridization to  globin  cDNA.  In  view  of  the 
problems  of  quantitation  by  this  method,  it  is 
difficult to  deduce the exact  relative amounts of 
globin  mRNA  in  basophilic  erythroblasts  and 
more  mature  erythroid  cells  including reticulo- 
cytes. Therefore, in order to confirm this conclu- 
sion concerning the presence of globin mRNA in 
immature  erythroid  cells,  the  content  of globin 
mRNA in immature or total erythroid cells was 
assayed by hybridization of extracted cytoplasmic 
RNA to globin cDNA in solution in the conven- 
tional manner. These results indicate that imma- 
ture erythroid cells from 14-day fetal livers contain 
on  average  about  60%  of  the  globin  mRNA 
content of total  14-day fetal liver cells. This value 
is too high to be accounted for solely by the mature 
erythroid cells surviving the treatment with anti- 
serum,  since  the  proportions  of  polychromatic 
erythroblasts,  orthochromatic  erythroblasts,  and 
reticulocytes are all reduced six- to seven-fold by 
such treatment (Table II). Therefore, these results 
obtained  independently of  in  situ  hybridization 
confirm that globin mRNAs are present in signifi- 
cant amounts in at least some immature erythro- 
blasts. However, as discussed above (see Results), 
the globin mRNAs synthesized in immature ery- 
throid cells may not comprise solely the adult a- 
and/3-globin chains. 
Relevance to Mechanism of Control of 
Globin Synthesis 
Whereas globin mRNA synthesis appears not to 
have been initiated or stabilized in the proerythro- 
blast,  basophilic erythroblasts  and  more  mature 
members of the  erythroid  cell series  accumulate 
globin mRNA. The fact that globin mRNA accu- 
mulates in basophilic erythroblasts is an important 
finding since hemoglobin cannot be detected to any 
significant extent until a  later stage  of erythroid 
cell development, i.e.  in the polychromatic eryth- 
roblast.  Since in  fetal  liver in vivo the  time  for 
transition of a  basophilic erythroblast to  a  poly- 
chromatic erythroblast  is  a  few  hours  (15),  this 
implies  that  there  may  be  some  translational 
control of globin synthesis at  this  stage  of fetal 
liver development. Using a sensitive assay, Terada 
et al. (3) have shown that an immature erythroid 
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day fetal liver cells with antiserum against mature 
red blood cells and containing not more than 7% 
hemoglobinized erythroblasts) synthesizes a- and 
B-globin chains at less than 6% of the rate for total 
fetal liver cells. The same workers showed that the 
proportion  of translatable globin  mRNA  in  the 
6  16S  RNA  fraction  from  these  immature  cells 
(determined by the ability to direct a- and B-globin 
synthesis in the Krebs ascites cell-free system) was 
less than  5%  of the corresponding value for total 
fetal liver cells. Taken  together with  the  present 
evidence,  this  would  appear  to  indicate  that  al- 
though globin mRNA sequences are synthesized in 
immature  (basophilic)  erythroblasts,  these  se- 
quences do not specify a- and B-globins or cannot 
be  translated  until modified in  some  way.  Since 
globin  mRNA  from  which  polyadenylic  acid 
(PolyA) sequences have been removed with poly- 
nucleotide  phosphorylase  can  still  be  translated 
(16), this modification of globin mRNA in imma- 
ture erythroblasts which prevents translation can- 
not be lack of the polyA sequences. Isak and Kar- 
sai (17) have presented evidence to suggest that al- 
though globin mRNA  is present in polysomes of 
immature (rabbit) erythroblasts, it cannot be trans- 
lated in the immature cell cytoplasm. 
Early Erythroid  Cell Development 
During the I Ith-12th day of fetal liver develop- 
ment, the proportion of proerythroblasts decreases 
from  about  80%  to  20%.  Most  cells in  the  pro- 
erythroblast  population  do  not  contain  globin 
mRNA.  However, during  development from  the 
1 lth to  13th days, an increasing proportion of the 
proerythroblast  population  contains  detectable 
amounts  of globin  mRNA,  as judged  by in  situ 
hybridization. This  suggests that  during  matura- 
tion  of the liver, an  increasing proportion of the 
proerythroblasts  begin  to  transcribe  the  globin 
gene.  This  is  analogous to  the  situation  in  vitro 
where  treatment  of  fetal  liver  cells  with  ery- 
thropoietin increases the proportion of proeryth- 
roblasts which contain giobin mRNA (D. Conkie, 
manuscript  in  preparation).  This  might  explain 
why,  during  the  llth-12th  day  of  fetal  liver 
development,  characteristically  small  basophilic 
cells appear which contain large amounts of globin 
mRNA. This cell is most probably a  small baso- 
philic erythroblast derived directly by division and 
differentiation of the  cells in  the  proerythroblast 
population in which expression of the globin gene 
has been initiated. 
The critical transition which results in the globin 
gene  being  activated may be connected  with  the 
fact that hemoglobin synthesis is no longer depend- 
ent  on  combined  RNA  synthesis  after  the 
12th-13th  day  of  fetal  liver development.  This 
change is probably caused by some change in the 
microenvironment of the fetal liver (5); Cole and 
Tarbutt (2) have concluded from cell kinetic data 
that this change is due to a dramatic reduction at 
about  the  14th  day  in  the  number  of  ery- 
thropoietin-sensitive stem  cells entering the  pro- 
erythroblast compartment. For this reason, in situ 
hybridization studies were performed of immature 
cells from 14-day fetal liver obtained by treatment 
with  antiserum.  In  fact,  the  proportion  and  ap- 
pearance  of cells  synthesizing globin  mRNA  in 
this  immature  cell fraction  (Fig.  8  a-b)  are  the 
same as described for cells from I 1-day livers (Fig. 
6  a-c).  Thus,  the  stabilization  of  hemoglobin 
synthesis with respect to continued RNA synthesis 
after the sudden inhibition at the 13th-14th day of 
stem cell differentiation could be explained simply 
as  follows, assuming  that  globin mRNA  is rela- 
tively stable:  on  the  llth  day,  most  proerythro- 
blasts, which are actively proliferating, have still to 
undergo the critical transition enabling synthesis of 
globin mRNA to occur, and therefore the capacity 
to synthesize hemoglobin subsequently is reduced 
by inhibition of RNA synthesis by treatment with 
actinomycin D;  by the  14th  day, most liver cells 
have  undergone  the  critical transition and  there- 
fore  inhibition  of RNA  synthesis  is  effective in 
preventing subsequent globin synthesis. 
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